Background Preliminary reports have described significant procoagulant events in patients
with coronavirus disease-2019 (COVID-19), including life-threatening pulmonary embolism …

COVID-19, the disease responsible for the devastating pandemic that began at the end of
2019, has been associated with a significantly increased risk of pulmonary thrombosis, even …

Objective To determine the incidence, characteristics, and risk factors of pulmonary
embolism (PE) among patients hospitalized for COVID-19. Patients and Methods We …

To determine, in patients with coronavirus disease 2019 (COVID-19) infection, the
associations of pulmonary embolism (PE) with mortality and risk factors for PE as well as the …

Abstract The Coronavirus Disease 2019 (COVID 19) has been reported in almost every
country in the world. Although a large proportion of infected individuals develop only mild …

Abstract Introduction Coronavirus disease 2019 (COVID-19) has been associated with
cardiovascular complications and coagulation disorders. Previous studies reported …

Introduction COVID-19 may predispose to both venous and arterial thromboembolism due to
excessive inflammation, hypoxia, immobilisation and diffuse intravascular coagulation …

Introduction The incidence, characteristics, and prognosis of pulmonary embolism (PE) in
Coronavirus disease 2019 (COVID-19) have been poorly investigated. We aimed to …

Recent studies suggest that thrombotic complications are a common phenomenon in the
novel SARS-CoV-2 infection. The main objective of our study is to assess cumulative …

Coronavirus disease 2019 (COVID-19) remains an increasing global pandemic, with
significant morbidity and mortality. Severe complications of COVID-19 associated with …